Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 22467088)

1.

Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels?

Taskapan H.

Int Urol Nephrol. 2012 Aug;44(4):1135-44. doi: 10.1007/s11255-012-0157-5. Epub 2012 Mar 31. Review.

PMID:
22467088
2.

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.

Gutiérrez OM.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1710-6. doi: 10.2215/CJN.02640310. Epub 2010 May 27. Review.

3.

Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.

Stubbs JR, Zhang S, Friedman PA, Nolin TD.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1965-73. doi: 10.2215/CJN.03130314. Epub 2014 Sep 2.

PMID:
25183657
5.

Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephron Clin Pract. 2008;110(1):c58-65. doi: 10.1159/000151534. Epub 2008 Aug 25.

PMID:
18724068
6.

Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.

Trakarnvanich T, Chalapipat O, Disthabanchong S, Kurathong S, Praditpornsilpa K, Stitchantrakul W, Chailurkit LO.

J Med Assoc Thai. 2010 Aug;93(8):885-91.

PMID:
20718162
7.

When is Vitamin D contraindicated in dialysis patients?

Martin KJ.

Semin Dial. 2009 May-Jun;22(3):247-9. doi: 10.1111/j.1525-139X.2009.00566.x. Review. No abstract available.

PMID:
19573001
8.

When is Vitamin D contraindicated in dialysis patients?

Evenepoel P.

Semin Dial. 2009 May-Jun;22(3):242-4. doi: 10.1111/j.1525-139X.2009.00564.x. Review. No abstract available.

PMID:
19572999
9.

Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism.

Kazama JJ, Gejyo F, Shigematsu T, Fukagawa M.

Ther Apher Dial. 2005 Aug;9(4):328-30. Review.

PMID:
16076376
10.

Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.

Dai B, David V, Alshayeb HM, Showkat A, Gyamlani G, Horst RL, Wall BM, Quarles LD.

Kidney Int. 2012 Nov;82(10):1061-70. doi: 10.1038/ki.2012.222. Epub 2012 Jun 27.

11.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].

Komaba H.

Clin Calcium. 2010 Jul;20(7):1028-36. doi: CliCa100710281036. Review. Japanese.

PMID:
20585181
12.

Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.

Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.

Nephrol Dial Transplant. 2013 Jan;28(1):153-61. doi: 10.1093/ndt/gfs411. Epub 2012 Nov 23.

13.

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.

Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.

Bone. 2012 Jun;50(6):1266-74. doi: 10.1016/j.bone.2012.02.634. Epub 2012 Mar 6.

PMID:
22425694
14.

When is Vitamin D contraindicated in dialysis patients?

Khosla N, Sprague SM.

Semin Dial. 2009 May-Jun;22(3):249-51. doi: 10.1111/j.1525-139X.2009.00567.x. Review. No abstract available.

PMID:
19573002
15.

When is Vitamin D Contraindicated in Dialysis Patients?

Goodman WG.

Semin Dial. 2009 May-Jun;22(3):245-7. doi: 10.1111/j.1525-139X.2009.00565.x. Review. No abstract available.

PMID:
19573000
16.

Vitamin D treatment in chronic kidney disease.

Andress DL.

Semin Dial. 2005 Jul-Aug;18(4):315-21. Review.

PMID:
16076355
17.

[Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].

Mazzaferro S, Pasquali M, Tartaglione L, Rotondi S, Pirrò G.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 49:S11-7. Italian.

PMID:
19941273
18.

[Frontiers in vitamin D; basic research and clinical application. Vitamin D and secondary hyperparathyroidism].

Tanaka H, Komaba H, Fukagawa M.

Clin Calcium. 2011 Nov;21(11):27-34. doi: CliCa111116111618. Review. Japanese.

PMID:
22040818
19.

Serum fibroblast growth factor-23 levels in chronic haemodialysis patients.

Ibrahim S, Rashed L.

Int Urol Nephrol. 2009;41(1):163-9. doi: 10.1007/s11255-008-9466-0. Epub 2008 Oct 7.

PMID:
18839328
20.

Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.

Uzum AK, Salman S, Telci A, Boztepe H, Tanakol R, Alagol F, Ozbey NC.

Eur J Endocrinol. 2010 Nov;163(5):825-31. doi: 10.1530/EJE-10-0591. Epub 2010 Aug 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk